Bessemer Group’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Bessemer Group’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-247,300	Closed	-$1.08M	–	1806
2020 Q2	$1.08M	Hold	247,300	–	–	﹤0.01%	750
2020 Q1	$937K	Hold	247,300	–	–	﹤0.01%	623
2019 Q4	$1.56M	Buy	247,300 +93,100	+60%	+$547K	0.01%	638
2019 Q3	$649K	Buy	+154,200	New	+$659K	﹤0.01%	812
2016 Q1	–	Sell	-750	Closed	-$4K	–	1813
2015 Q4	$4K	Buy	+750	New	+$4.25K	﹤0.01%	1440
2015 Q3	–	Sell	-143	Closed	-$1K	–	1861
2015 Q2	$1K	Hold	143	–	–	﹤0.01%	1479
2015 Q1	$2K	Sell	143 -6	-4%	-$82	﹤0.01%	1454
2014 Q4	$2K	Hold	149	–	–	﹤0.01%	1456
2014 Q3	$3K	Hold	149	–	–	﹤0.01%	1198
2014 Q2	$2K	Buy	+149	New	+$1.41K	﹤0.01%	1334

Other funds holding BDSI

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Bessemer Group's BDSI Position: Q3 2020 in Review

Bessemer Group sold out of BioDelivery Sciences International, Inc. (BDSI) in Q3 2020, closing a stake of 247,300 shares — an estimated $1.08M sold.

Bessemer Group first reported a position in BDSI in Q2 2014 and held it in 10 quarters. The position peaked at $1.56M in Q4 2019. 147 funds tracked by Wall St. Rank hold BDSI as of Q3 2020.

Bessemer Group reported no remaining BioDelivery Sciences International, Inc. position as of Q3 2020 after selling out during the quarter.
Bessemer Group sold 247,300 BioDelivery Sciences International, Inc. shares in Q3 2020, an estimated $1.08M.
Bessemer Group first reported a position in BioDelivery Sciences International, Inc. in Q2 2014 and held it in 10 quarters.
Bessemer Group's BioDelivery Sciences International, Inc. position peaked at $1.56M in Q4 2019.
147 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q3 2020.

Based on Bessemer Group's 13F filing for Q3 2020, filed 12 Nov 2020.